OccuLogix Regains Compliance With NASDAQ Continued Listing Requirements
30 Octubre 2008 - 6:15AM
Marketwired
OccuLogix, Inc. (NASDAQ: OCCXD)(TSX: OC) announced today that it
has been notified by the NASDAQ Listing and Hearing Review Council
(the "Listing Council") that OccuLogix has demonstrated compliance
with the U.S.$1 minimum bid price rule and the requirement to
maintain stockholders' equity in the minimum amount of
U.S.$2,500,000. The Listing Council confirmed that the listing
review is now closed and that the Company's securities will remain
listed on The NASDAQ Capital Market.
About OccuLogix, Inc.
OccuLogix (www.occulogix.com) is a healthcare company focused on
ophthalmic devices for the diagnosis and treatment of age-related
eye diseases. Its wholly-owned subsidiary, OcuSense, Inc.
(www.ocusense.com), is an in-vitro diagnostics company developing
and commercializing novel, laboratory-on-a chip technologies that
enable eye care practitioners to test for highly sensitive and
specific biomarkers in tears at the point-of-care.
Forward-Looking Statements
This press release may contain forward-looking statements. These
statements relate to future events and are subject to risks,
uncertainties and assumptions about the Company. These statements
are only predictions based on our current expectations and
projections about future events. You should not place undue
reliance on these statements. Actual events or results may differ
materially. Many factors may cause our actual results to differ
materially from any forward-looking statement, including the
factors detailed in our filings with the Securities and Exchange
Commission and Canadian securities regulatory authorities,
including but not limited to our Forms 10-K and 10-Q. We do not
undertake to update any forward-looking statements.
Contacts: OccuLogix, Inc. Eric Donsky Chief Executive Officer
(858) 794-1400 Email: edonsky@tearlab.com Website:
www.occulogix.com
Occulogix (MM) (NASDAQ:OCCXD)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Occulogix (MM) (NASDAQ:OCCXD)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Occulogix (MM) (NASDAQ): 0 recent articles
Más de OccuLogix, Inc. Artículos de Noticias